Medical Devices & Surgical Technology Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices & Surgical Technology Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Allergy & Immunology
Verus donates 5,000 epinephrine auto-injector demonstrators for Anaphylaxis Day at meeting
April 11th, 2006
Verus Pharmaceuticals, Inc., a pediatric-oriented specialty pharmaceutical company, announced it will donate 5,000 Twinject demonstrator devices for Anaphylaxis Day activities during the 2006 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting. Anaphylaxis Day aims to educate physicians, healthcare professionals and the public about anaphylaxis, a severe, life-threatening systemic allergic reaction. Twinject, an epinephrine auto-injector indicated for the emergency treatment of severe allergic reactions, is approved by the U.S. Food and Drug Administration (FDA) and contains two doses of epinephrine in a single device. ...
Source: Medical Devices & Surgical Technology Week (2006-04-11)
|
